Browsing: Homepage Slider
Listen to our exclusive interview with Philip A Philip to find out about novel agents and strategies on the horizon for pancreatic cancer.
In this interview, Illumina’s Chief Scientist, David Bentley, speaks about the 100,000 Genomes Project which could transform the way cancer patients are cared for.
Editor, Jade Parker recently spoke with world-renowned sarcoma expert, Robin L Jones. In this interview discover challenges in the diagnosis, treatment and clinical trials of sarcoma and other rare tumors.
Targeted sequencing focused on cancer-related genes provides comprehensive assessment of tumor mutational burden, with results comparable to whole-exome sequencing.
NGS-guided assessment of interactions between tumors and the immune system leads to new discoveries in immuno-oncology. Introduction Traditionally the…
The European Commission has recently approved dinutuximab beta for high risk neuroblastoma patients over the age of 12 months, making it the only approved immunotherapy in Europe for this group of patients.
Live event: Thursday, July 27, 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST].
Find out how diet, physical activity and body weight affect the risk of gastrointestinal cancesr and how people can reduce their risk of developing the disease.